rs202085145
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 1P and 5B. PP3BP6BS2
The NM_001032386.2(SUOX):c.228G>T(p.Arg76Ser) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000583 in 1,613,944 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001032386.2 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
- isolated sulfite oxidase deficiencyInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen, G2P
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SUOX | NM_001032386.2 | c.228G>T | p.Arg76Ser | missense_variant, splice_region_variant | Exon 4 of 5 | ENST00000266971.8 | NP_001027558.1 | |
| SUOX | NM_000456.3 | c.228G>T | p.Arg76Ser | missense_variant, splice_region_variant | Exon 5 of 6 | NP_000447.2 | ||
| SUOX | NM_001032387.2 | c.228G>T | p.Arg76Ser | missense_variant, splice_region_variant | Exon 3 of 4 | NP_001027559.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000579 AC: 88AN: 152086Hom.: 1 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.00103 AC: 257AN: 250708 AF XY: 0.000907 show subpopulations
GnomAD4 exome AF: 0.000584 AC: 853AN: 1461740Hom.: 3 Cov.: 31 AF XY: 0.000589 AC XY: 428AN XY: 727150 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000578 AC: 88AN: 152204Hom.: 1 Cov.: 31 AF XY: 0.000524 AC XY: 39AN XY: 74410 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Sulfite oxidase deficiency Pathogenic:1Uncertain:2Benign:2
- -
- -
- -
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
- -
not specified Benign:1
Variant summary: SUOX c.228G>T (p.Arg76Ser) results in a non-conservative amino acid change in the encoded protein sequence and is within the exonic splice region. Three of five in-silico tools predict a benign effect of the variant on protein function. Several computational tools predict a significant impact on normal splicing: Three predict the variant weakens a 5' donor site. One predict the variant no significant impact on splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.001 in 250708 control chromosomes, predominantly at a frequency of 0.0012 within the Latino subpopulation in the gnomAD database, including 1 homozygotes. The observed variant frequency within Latino control individuals in the gnomAD database is approximately 1 fold of the estimated maximal expected allele frequency for a pathogenic variant in SUOX causing Sulfite Oxidase Deficiency phenotype (0.0011), strongly suggesting that the variant is a benign polymorphism found primarily in populations of Latino origin. To our knowledge, no occurrence of c.228G>T in individuals affected with Sulfite Oxidase Deficiency has been reported. At least one publication reports experimental evidence evaluating an impact on splicing, suggesting the variant resulted in reduced normal transcript at about 39% of WT and the exon-skipped transcript was significantly enhanced by RT-PCR in HEK293T cells, however such data conflict with the subsequent presentation in the same paper, which does not allow convincing conclusions about the variant effect (Bastarache_2018). The following publication have been ascertained in the context of this evaluation (PMID: 29590070). Four submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Multiple submitters reported the variant with conflicting assessments (Pathogenic, n=1; Uncertain significance, n=1; Benign, n=2). Based on the evidence outlined above, the variant was classified as likely benign. -
SUOX-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Inborn genetic diseases Benign:1
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at